Advertisement
Advertisement

LGVN

LGVN logo

Longeveron Inc. Common Stock

1.12
USD
Sponsored
0.00
0.00%
Apr 15, 15:58 UTC -4
Closed
exchange

After-Market

1.11

-0.01
-0.45%

LGVN Earnings Reports

Positive Surprise Ratio

LGVN beat 6 of 17 last estimates.

35%

Next Report

Date of Next Report
May 08, 2026
Estimate for Q1 26 (Revenue/ EPS)
$333.54K
/
-$0.16
Implied change from Q4 25 (Revenue/ EPS)
-8.62%
/
-30.43%
Implied change from Q1 25 (Revenue/ EPS)
-12.46%
/
-52.94%

Longeveron Inc. Common Stock earnings per share and revenue

On Mar 17, 2026, LGVN reported earnings of -0.23 USD per share (EPS) for Q4 25, beating the estimate of -0.42 USD, resulting in a 45.67% surprise. Revenue reached 365.00 thousand, compared to an expected 150.96 thousand, with a 141.79% difference. The market reacted with a -2.48% price change (close before vs. close after earnings).
Looking ahead to Q1 26, -- analysts forecast an EPS of -0.16 USD, with revenue projected to reach 333.54 thousand USD, implying an decrease of -30.43% EPS, and decrease of -8.62% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Lexaria Bioscience Corp. Common Stock
Report Date
Apr 13, 2026 For Q2 26
Estimate
-$0.09
Actual
-$0.06
Surprise
+38.08%
logo
Sunshine Biopharma Inc.
Report Date
Apr 03, 2026 For Q4 25
Estimate
-$0.27
Actual
-$0.54
Surprise
-96.08%
logo
Pharvaris N.V. Ordinary Shares
Report Date
Apr 02, 2026 For Q4 25
Estimate
-$0.63
Actual
-$0.72
Surprise
-13.69%
logo
Innate Pharma S.A. ADS
Report Date
Apr 01, 2026 For Q1 26
Estimate
-$0.12
Actual
-$0.55
Surprise
-353.80%
FAQ
For Q4 2025, Longeveron Inc. Common Stock reported EPS of -$0.23, beating estimates by 45.67%, and revenue of $365.00K, 141.79% above expectations.
The stock price moved down -2.48%, changed from $0.50 before the earnings release to $0.48 the day after.
The next earning report is scheduled for May 08, 2026.
Based on -- analysts, Longeveron Inc. Common Stock is expected to report EPS of -$0.16 and revenue of $333.54K for Q1 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement